Can tiotropium add-on therapy safely improve clinical outcomes in children and adolescents with persistent asthma?

Ann Allergy Asthma Immunol. 2020 Jul;125(1):109-110. doi: 10.1016/j.anai.2020.04.022. Epub 2020 May 1.

Authors

Dan Yang¹, Qian Peng¹, Tingxuan Huang¹, Xinning Guo¹, Chuntao Liu²

Affiliations

¹ Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital, Sichuan University, Chengdu, China.
² Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital, Sichuan University, Chengdu, China. Electronic address: [email protected].

PMID: 32371245
DOI: 10.1016/j.anai.2020.04.022

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Adolescent
Adrenal Cortex Hormones / therapeutic use
Asthma / drug therapy*
Bronchodilator Agents / therapeutic use*
Child
Drug Therapy, Combination / methods*
Female
Humans
Male
Tiotropium Bromide / therapeutic use*

Substances

Adrenal Cortex Hormones
Bronchodilator Agents
Tiotropium Bromide